CellGenix GmbH, a global supplier of raw and ancillary materials for cell and gene therapies, has completed the second phase of its facility expansion. CellGenix has reconstructed and expanded its production facility for cytokines and implemented an automated filling and freeze-drying line.   By implementing an automated filling and freeze-drying line and increasing bulkware production footprint, finished product capacity for cytokines is substantially increased. This continues to enable CellGen...